PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
CACG vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

CACG vs. ARKG

Last updated May 11, 2025

Compare and contrast key facts about ClearBridge All Cap Growth ESG ETF (CACG) and ARK Genomic Revolution Multi-Sector ETF (ARKG).

CACG and ARKG are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CACG is an actively managed fund by Franklin Templeton. It was launched on May 3, 2017. ARKG is an actively managed fund by ARK Investment Management. It was launched on Oct 31, 2014.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CACG or ARKG.

Correlation

The correlation between CACG and ARKG is 0.62, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

CACG vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ClearBridge All Cap Growth ESG ETF (CACG) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Returns By Period

CACG

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

ARKG

YTD

-10.26%

1M

9.14%

6M

-18.40%

1Y

-15.14%

5Y*

-14.24%

10Y*

0.04%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

CACG vs. ARKG - Expense Ratio Comparison

CACG has a 0.53% expense ratio, which is lower than ARKG's 0.75% expense ratio.

ARKG
ARK Genomic Revolution Multi-Sector ETF
CACG
ClearBridge All Cap Growth ESG ETF

Risk-Adjusted Performance

CACG vs. ARKG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
CACG
The Risk-Adjusted Performance Rank of CACG is 7373
Overall Rank
The Sharpe Ratio Rank of CACG is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of CACG is 7474
Sortino Ratio Rank
The Omega Ratio Rank of CACG is 7373
Omega Ratio Rank
The Calmar Ratio Rank of CACG is 6969
Calmar Ratio Rank
The Martin Ratio Rank of CACG is 7474
Martin Ratio Rank
ARKG
The Risk-Adjusted Performance Rank of ARKG is 88
Overall Rank
The Sharpe Ratio Rank of ARKG is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of ARKG is 1010
Sortino Ratio Rank
The Omega Ratio Rank of ARKG is 1010
Omega Ratio Rank
The Calmar Ratio Rank of ARKG is 1010
Calmar Ratio Rank
The Martin Ratio Rank of ARKG is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CACG vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ClearBridge All Cap Growth ESG ETF (CACG) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Loading data...

Dividends

CACG vs. ARKG - Dividend Comparison

Neither CACG nor ARKG has paid dividends to shareholders.

TTM20242023202220212020201920182017
CACG
ClearBridge All Cap Growth ESG ETF		0.05%0.05%0.34%0.34%2.92%0.47%0.64%0.68%0.24%
ARKG
ARK Genomic Revolution Multi-Sector ETF		0.00%0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Drawdowns

CACG vs. ARKG - Drawdown Comparison

Loading data...

Volatility

CACG vs. ARKG - Volatility Comparison

Loading data...